Carrie L. Dul, M.D., F.A.C.P., began her career in medicine as an R.N., completing her undergraduate degrees in psychology, biopsy and nursing science at the University of Michigan-Dearborn and Wayne State University with highest honors. She attended the University of North Carolina at Chapel Hill Medical School from 1995-1999. She then went on to complete both her Internal Medicine Residency and Hematology and Medical Oncology Fellowship at Oregon Health and Science University in Portland, Oregon. She returned to the Detroit metropolitan area to join Great Lakes Cancer Management Specialists in the fall of 2005. She is certified by the American Board of Internal Medicine, Hematology and Medical Oncology. Her professional memberships include the American Society of Clinical Oncology, the American Society of Hematology and the American College of Physicians.
Dr. Dul has a strong interest in the care of breast cancer patients and women's health in relation to oncology and hematology diagnoses. She completed special clinical training in breast cancer during her fellowship and established an active breast cancer practice. She has participated in clinical trials, written and given review lectures for community oncologists, patients and her academic community in these areas. She is designated as a Breast Specialist in the St. John Health Breast Care Program which has received national accreditation from the National Accreditation Program for Breast Health Centers. She is a member of the National Consortium of Breast Centers. She serves on the Physician Advisory Board at The Lake House, a community cancer support program.
She has been recognized by her peers for exceptional compassion in caring for patients with a humanism award. Dr. Dul serves as the Principal Investigator for St. John Hospital and Medical Center, participating in the MCRC CCOP (Michigan Cancer Research Consortium, Community Clinical Oncology Program). MCRC CCOP participates in several nationally recognized research organizations offering a wide variety of clinical trials. She is a strong advocate for continued research in oncology and participation in clinical trials.